Patient Engagement
Made better with AI
AiCure's H.Code is the world’s first patient engagement AI, a comprehensive platform that extends the reach of your care team to support clinical trial participants at home.
Change the way you look at participant behavior
H.Code, by AiCure, uses AI-powered computer vision, synchronous chat, and predictive analytics to observe and assist trial participants through their smartphone—revolutionizing access and participation, improving statistical power, and deepening our understanding of the relationship between patient behavior and trial outcomes.
eCOA - ePRO
Capture participant responses and configure response visibility for sites and/or sponsors/CROs as needed.
Adherence & Dosing
Adherence is more than just pill counts. Anticipate and manage it proactively to prevent dropouts.
Responsible AI
From the start, AiCure has integrated diversity into its patient engagement AI platform to eliminate bias.
What clinical teams are saying
Clinical teams are using H.Code to enhance and streamline their clinical research processes.
"Having worked with AiCure, they are probably the most advanced in facial recognition and mapping software and the algorithms underlying that to detect subtle clinical changes.”
Matthew Leoni, MD MBA, VP, Global Clinical Development at Cerevel Therapeutics
“The thing I’ve been focusing on is really using AiCure for, rather than a passive data collection tool, is to drive action.”
Sarah Titus, Director of Clinical Operations & Development at Sage Therapeutics
"We did see drop-out rates fall considerably and cut down by more than half. That for us is a big win."
Kyle Holen, MD, Head of Development Design Center at Abbvie
Breakthrough Research on Early Termination
Our research shows that medication adherence captured through AiCure’s AI-powered platform, H.Code, can serve as a marker for participant retention and that early adherence is predictive of future early termination risk. This technology, coupled with AiCure’s central monitoring framework, Clinical Site Services (CSS), reduced early termination rates for adherent participants to just 7.8% across 28 phase I-IV clinical trials with over 4,000 patients representative of 43 countries.
Built for every clinical trial
Make the trial experience better, for everyone
H.Code is designed to be a bridge between your patients and your clinical team. Our unique approach combines cutting-edge patient engagement AI technology with extensive site expertise in one solution, making clinical trials more convenient and accessible for participants and more manageable and effective for clinical sites and study teams.
Upcoming Events
Want to talk in person? We would love to meet with you at any of the following events: